Back to Search
Start Over
Connective tissue growth factor expression and induction by transforming growth factor-β is abrogated by simvastatin via a Rho signaling mechanism
- Source :
- American Journal of Physiology-Lung Cellular and Molecular Physiology. 287:L1323-L1332
- Publication Year :
- 2004
- Publisher :
- American Physiological Society, 2004.
-
Abstract
- Connective tissue growth factor (CTGF), a potent profibrotic mediator, acts downstream and in concert with transforming growth factor (TGF)-β to drive fibrogenesis. Significant upregulation of CTGF has been reported in fibrogenic diseases, including idiopathic pulmonary fibrosis (IPF), and is partly responsible for associated excessive fibroblast proliferation and extracellular matrix deposition, but no effective therapy exists for averting such fibrogeneic events. Simvastatin has reported putative antifibrotic actions in renal fibroblasts; this study explores such actions on human IPF-derived and normal lung fibroblasts and examines associated driving mechanisms. Simvastatin reduces basal CTGF gene and protein expression in all fibroblast lines, overriding TGF-β induction through inhibition of the cholesterol synthesis pathway. Signaling pathways driving simvastatin's effects on CTGF/TGF-β interaction were evaluated using transient reporter transfection of a CTGF promoter construct. Inhibition of CTGF promoter activity by simvastatin was most marked at 10 μM concentration, reducing activity by 76.2 and 51.8% over TGF-β-stimulated cultures in IPF and normal fibroblasts, respectively. We also show that geranylgeranylpyrophosphate (GGPP), but not farnesylpyrophosphate, induces CTGF promoter activity following simvastatin inhibition by 55.3 and 31.1% over GGPP-negative cultures in IMR90 and IPF-derived fibroblasts, respectively, implicating small GTPase Rho involvement rather than Ras in these effects. Indeed, the specific Rho inhibitor C3 exotoxin significantly ( P < 0.05) suppressed TGF-β-induced CTGF promoter activity in transfected lung fibroblasts, a finding further supported by transfection of dominant-negative and constitutively active RhoA constructs, thus demonstrating that simvastatin through a Rho signaling mechanism in lung fibroblasts can modulate CTGF expression and interaction with TGF-β.
- Subjects :
- rho GTP-Binding Proteins
Pulmonary and Respiratory Medicine
Simvastatin
Physiology
medicine.medical_treatment
Connective tissue
Biology
Cell Line
Immediate-Early Proteins
Mediator
Downregulation and upregulation
Transforming Growth Factor beta
Physiology (medical)
medicine
Humans
Lung
integumentary system
Reverse Transcriptase Polymerase Chain Reaction
Growth factor
Connective Tissue Growth Factor
Cell Biology
Fibroblasts
Recombinant Proteins
Insulin-Like Growth Factor Binding Proteins
CTGF
medicine.anatomical_structure
Gene Expression Regulation
Cell culture
Cancer research
Intercellular Signaling Peptides and Proteins
medicine.drug
Transforming growth factor
Subjects
Details
- ISSN :
- 15221504 and 10400605
- Volume :
- 287
- Database :
- OpenAIRE
- Journal :
- American Journal of Physiology-Lung Cellular and Molecular Physiology
- Accession number :
- edsair.doi.dedup.....043530c398b92bf618ba5f9e1c30379a
- Full Text :
- https://doi.org/10.1152/ajplung.00447.2003